Christopher Cabell Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Christopher Cabell.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Christopher Cabell. Christopher Cabell is a EVP, Head of R&D, and CMO in ARENA PHARMACEUTICALS INC ($ARNA) and a Director in Pulmatrix, Inc. ($PULM).
Address: C/O ARENA PHARMACEUTICALS, INC. 6154 NANCY RIDGE DRIVE SAN DIEGO 92121 CA
Companies in which Christopher Cabell is an Insider
ARENA PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Christopher Cabell: EVP, Head of R&D, and CMO
Holdings: 2,500 shares
Current Value: $3,725
Latest Transaction: Nov 30 2020
$ARNA Market Capitalization: $357.67M
$ARNA Previous Close: $1.49
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Pulmatrix, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Christopher Cabell: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 01 2021
$PULM Market Capitalization: $73.21M
$PULM Previous Close: $4.92
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Christopher Cabell
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 01 2021 | PULM | Pulmatrix, Inc. | Cabell Christopher | Director | Option Exercise | A | 1.47 | 15,000 | 22,050 | 15,000 | |
| Feb 01 2021 | PULM | Pulmatrix, Inc. | Cabell Christopher | Director | Option Exercise | A | 1.47 | 15,000 | 22,050 | 15,000 | |
| Nov 30 2020 | ARNA | ARENA PHARMACEUTIC ... | Cabell Christopher | EVP, Head of R&D, a ... | Option Exercise | M | 0.00 | 2,500 | 0 | 5,000 | |
| Nov 30 2020 | ARNA | ARENA PHARMACEUTIC ... | Cabell Christopher | EVP, Head of R&D, a ... | Payment of Exercise | F | 65.50 | 1,099 | 71,985 | 1,401 | 2.5 K to 1.4 K (-43.96 %) |
| Nov 30 2020 | ARNA | ARENA PHARMACEUTIC ... | Cabell Christopher | EVP, Head of R&D, a ... | Buy | M | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
| Jul 17 2020 | ARNA | ARENA PHARMACEUTIC ... | Cabell Christopher | EVP, Head of R&D, a ... | Option Exercise | M | 26.28 | 13,000 | 341,640 | 47,000 | |
| Jul 17 2020 | ARNA | ARENA PHARMACEUTIC ... | Cabell Christopher | EVP, Head of R&D, a ... | Sell | S | 68.00 | 13,000 | 884,000 | 0 | 13 K to 0 (-100.00 %) |